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After admission, an initial treatment of oral haloperidol (1 mg/day) was administered, rather than second-generation antipsychotics (which are associated with tendency of metabolic syndrome and increased risk of stroke), along with a physical work-up to test for possible organic etiology. The auditory hallucination was still noted and haloperidol was increased to 5 mg/day. A brain magnetic resonance imaging (MRI) scan revealed no evidence of an interval change or new intracranial lesions, compared with MRI scans performed 2 years prior. Functional MRI (fMRI) was not performed, so we failed to specify the relation between clinical hallucinations and fMRI modifications. The complete blood cells, electrolyte levels, and renal and liver function were normal. The antiphospholipid, lupus anticoagulant, IgG immunoglobulin, and anti-nuclear-and anti-double-stranded DNA autoantibodies were also all within the normal range. During her hospital stay, the patient's psychotic symptoms gradually improved on haloperidol (5 mg/day); for progressive extrapyramidal symptoms, haloperidol was replaced with chlorpromazine (25 mg/day) after discharge a few weeks later, with a fair response. No exacerbation of the psychosis was noted during follow-ups over the next 3 years at our clinic.
In our patient, idiopathic Sneddon syndrome was diagnosed. 3 She had deafness and MRI showed multiple cerebral infarctions. The livedo reticularis was noted over her four limbs and the skin biopsy revealed thrombosis of subcutaneous arterioles. Systemic lupus erythematosus, polyarteritis nodosa, cryoglobulinemia, livedoid vasculitis, cold agglutinin disease, arteriosclerosis, and others were all excluded.
1 During this hospitalization, her autoimmune factors were normal and Sneddon syndrome was still considered. Her psychotic symptoms were fully remitted under a low dose of antipsychotics (haloperidol at 5 mg/day in the ward, and subsequent chlorpromazine at 25 mg/day in the clinic), without recurrence of psychosis over the following 3 years.
There may be some debate about whether the patient's symptoms indicated a comorbid primary psychosis or were secondary to Sneddon syndrome. However, the evidence suggests that this is not a comorbid primary psychosis, because of the absence of a family history of psychiatric disorder, the relatively late onset of the psychotic symptoms, and a lack of concomitant delusions.
We hypothesize that the psychotic symptoms were secondary to Sneddon syndrome. Suicide risk should be considered in cases where Sneddon syndrome is the diagnosis; a low dose of antipsychotics may be effective for controlling the symptoms and preventing side-effects.
The protocol for the research project has been approved by TMU-JIRB (Taipei Medical University-Joint Institutional Review Board, No. N201604035, protocol version/date: version 1.0/2016/04/05, informed consent forms: waiver of informed consent), and it conforms to the provisions of the Declaration of Helsinki.
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Mitsuda psychosis and holodysphrenia revisited: An atypical psychosis in a patient with parieto-occipital paroxysmal electroencephalographic activity and high unconjugated bilirubin doi:10.1111/pcn.12487 R ECENT WORKS HAVE found a positive correlation between bilirubin concentration and schizophrenia symptoms. [1] [2] [3] It seems that unconjugated bilirubin (UCB), through its neurotoxic effect, 4 may be particularly interesting as a biomarker candidate in the distinction between schizophrenia and bipolar disorder. 5, 6 We present a patient with atypical psychosis, high UCB levels, and electroencephalographic (EEG) changes.
A 47-year-old woman was seen in a psychiatric emergency room following 3 days of mutism, anorexia, and insomnia. Over the last month there had also been mental confusion, ruinous persecutory delusion, and auditory hallucinations (two voices commenting on her behavior). We found no changes either in the patient's mood or memory. One year previously, her mother, suffering from an undisclosed mental disorder, had committed suicide. At examination, the patient presented a slightly reddish jaundice. Laboratory tests revealed high levels of UCB (1.57 mg/dL) with hemoglobinuria (0.50 mg/dL). EEG revealed frequent right parieto-occipital paroxysmal activity, but brain computed tomography and lumbar puncture were negative. The patient was diagnosed with psychotic disorder due to medical condition and treated with sodium valproate 1500 mg and olanzapine 10 mg. Full remission of symptoms was achieved and the patient was referred for further study. At internal medicine © 2016 The Authors Psychiatry and Clinical Neurosciences © 2016 Japanese Society of Psychiatry and Neurology consultation, no hepatic pathology was found and she was diagnosed with self-limited hemolysis of undisclosed origin, with UCB level rapidly returning to normal values. At the neurology consultation, a new EEG found no abnormal activity at all. At the psychiatry community outpatient clinic, there was no clinical recurrence. After 12 months of follow-up, there were no neuropsychiatric signs or symptoms, so the patient was sent back to the general practitioner with neither antipsychotic nor antiepileptic medication.
This clinical vignette suggests classic holodysphrenia, an endogenous group of psychoses with relapsing/remitting course and profound disintegration of mental activity during episodes, 7 corresponding nowadays to the DSM-5's brief psychotic disorder or schizophreniform disorder. Some holodysphrenia cases were related to quite understudied medical conditions, thus overlapping Mitsuda's (atypical) psychoses, 8 somewhere in between the schizophrenia and the epileptic psychosis spectrum. 9 This case emphasizes the importance of a high level of clinical suspicion and of careful medical examination of every patient at the psychiatric emergency room. Furthermore, it also highlights the plausible correlation between high UCB levels and psychosis, especially on the schizophrenia spectrum, which shall be the object of further study. The protocol for the research project has been approved by the Ethics Committee of Lisbon Psychiatric Hospital Center and it conforms to the provisions of the Declaration of Helsinki. Informed consent was attained from the patient on publishing this report.
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